Many patients struggle with therapeutic control, adverse effects, and costs of psoriasis treatments, prompting a renewed ...

In this edition of The People's Pharmacy, Joe and Teresa Graedon also hear from a reader wondering about COVID-19-induced insulin resistance.

The Food and Drug Administration (FDA) announced that it has accepted the supplemental New Drug Application (sNDA) for roflumilast foam 0.3% in adults and adolescents with scalp and body psoriasis ...

Does your hair's length affect how you take care of, maintain, and stop scalp psoriasis from returning? Let's talk about it.

The overactive immune response in psoriasis can influence your brain’s chemicals, which can lead to both depression and ...

Having a dry, flaky scalp is one of the most frustrating scalp concerns to deal with. Whether from suffering from psoriasis ...

Flakes won’t go away? You might be dealing with scalp psoriasis instead of dandruff! Here's how to know the difference ...

The GN-037 Phase 2 trial met the primary endpoint: treatment success, defined as the percentage of patients with at least a 2 ...

In this randomized clinical trial, home-based phototherapy was as effective as office-based phototherapy for plaque or ...

A new study utilised data from the UK Biobank to shed light on a potential causal link between psoriasis and lung and breast ...

The FDA has already approved Zoryve cream (0.3% and 0.15%) for plaque psoriasis and atopic dermatitis in adults and children ...

Access to adequate care for psoriasis is inconsistent across Europe and the condition remains misunderstood and undertreated.